STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha

PurposeThe precise molecular targets of interferon-alpha (IFN-α) therapy of melanoma are unknown but likely involve signal transducer and activator of transcription 1 (STAT1) signal transduction within host immune effector cells. We hypothesized that microarray analysis could be utilized to identify candidate molecular targets important for mediating the anti-tumor effect of exogenously administered IFN-α.Experimental MethodsTo identify the STAT1-dependent genes regulated by IFN-α, the gene expression profile of splenocytes from wild type (WT) and STAT1−/− mice was characterized.ResultsThis analysis identified 30 genes that required STAT1 signal transduction for optimal expression in response to IFN-α (p < 0.001). These genes include granzyme b (Gzmb), interferon regulatory factor 7 (Irf7), Fas death domain-associated protein (Daxx), and lymphocyte antigen 6 complex, locus C (Ly6c). The expression of 20 genes was found to be suppressed in the presence of STAT1 including chemokine ligand 2 (Ccl2), Ccl5, and Ccl7. Nineteen genes were significantly upregulated in murine splenocytes following treatment with IFN-α regardless of the presence of STAT1 including CD86, lymphocyte antigen 6 complex, locus A (Ly6a), and Tap binding protein (Tapbp). The expression of representative IFN-responsive genes was confirmed at the transcriptional level by Real Time PCR.ConclusionThis report is the first to demonstrate that STAT1-mediated signal transduction plays a major role in the transcriptional response of murine immune cells to IFNα.

[1]  E. Esplugues,et al.  The Adaptor Protein 3BP2 Binds Human CD244 and Links this Receptor to Vav Signaling, ERK Activation, and NK Cell Killing1 , 2005, The Journal of Immunology.

[2]  E. Borden,et al.  IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[3]  J. Ash,et al.  Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal Infection , 2003, Journal of Virology.

[4]  J. Kirkwood,et al.  Interferon-alpha in tumor immunity and immunotherapy. , 2002, Cytokine & growth factor reviews.

[5]  M. Grace,et al.  Interferon-alpha as an immunotherapeutic protein. , 2002, Journal of leukocyte biology.

[6]  M. Simon,et al.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Syed M. Rizvi,et al.  Direct peptide-regulatable interactions between MHC class I molecules and tapasin , 2006, Proceedings of the National Academy of Sciences.

[8]  G. Lesinski,et al.  Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. , 2004, Journal of the National Cancer Institute.

[9]  A. Goldberg,et al.  Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. , 1995, Journal of immunology.

[10]  F. Belardelli,et al.  Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I. , 1982, International journal of cancer.

[11]  Richard M. Ransohoff,et al.  Stat1-independent regulation of gene expression in response to IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Rubegni,et al.  Different effects of interferon‐α on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis , 2003, The British journal of dermatology.

[13]  E. Usherwood,et al.  CD80 and CD86 Control Antiviral CD8+ T-Cell Function and Immune Surveillance of Murine Gammaherpesvirus 68 , 2006, Journal of Virology.

[14]  S. Jalkanen,et al.  Ly6C Induces Clustering of LFA-1 (CD11a/CD18) and Is Involved in Subtype-Specific Adhesion of CD8 T Cells 1 , 2003, The Journal of Immunology.

[15]  U. Wahn,et al.  Effects of interferon‐α on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen‐specific T cells , 1996, European journal of immunology.

[16]  G. Lesinski,et al.  The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse , 2003 .

[17]  G. Lesinski,et al.  IFN-α-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine Signaling Proteins1 , 2007, The Journal of Immunology.

[18]  D. Levy,et al.  Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[19]  D. Jukic,et al.  Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  E. Borden,et al.  IFN-α2b and thalidomide synergistically inhibit tumor-induced angiogenesis , 2003 .

[21]  F. Fallarino,et al.  Stat 1 CTL In Vivo Requires Host Expression of Cutting Edge : Differentiation of Antitumor , 1999 .

[22]  B. Bisikirska,et al.  Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  A. Frey.  Myeloid suppressor cells regulate the adaptive immune response to cancer. , 2006, The Journal of clinical investigation.

[24]  G. Lesinski,et al.  The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line. , 2004, The Journal of surgical research.

[25]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[26]  B. Williams,et al.  Signal transduction in the interferon system. , 1998, Seminars in oncology.

[27]  F. Belardelli,et al.  Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases , 1990, International journal of cancer.

[28]  C. Biron.  Interferons α and β as Immune Regulators—A New Look , 2001 .

[29]  Chilakamarti V. Ramana,et al.  Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Garbe,et al.  Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. , 1990, The Journal of investigative dermatology.

[31]  F. Belardelli,et al.  Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. II. Role of host mechanisms , 1982, International journal of cancer.

[32]  M. Atkins,et al.  Autoimmunity and immunotherapy for cancer. , 2006, The New England journal of medicine.

[33]  S. Hedrick,et al.  A Pivotal Role for the Multifunctional Calcium/Calmodulin-Dependent Protein Kinase II in T Cells: From Activation to Unresponsiveness1 , 2005, The Journal of Immunology.

[34]  Tetsuo Nakamura,et al.  Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon. , 2006, The Kobe journal of medical sciences.

[35]  F. Belardelli,et al.  Interaction of IFN α/β with host cells essential to the early inhibition of friend erythroleukemia visceral metastases in mice , 1994 .

[36]  C. Biron.  Interferons alpha and beta as immune regulators--a new look. , 2001, Immunity.

[37]  M. Grace,et al.  Interferon‐α as an immunotherapeutic protein , 2002, Journal of Leukocyte Biology.

[38]  J. Darnell,et al.  Transcriptional regulation of interferon-stimulated genes: a DNA response element and induced proteins that recognize it. , 1988, Cold Spring Harbor symposia on quantitative biology.

[39]  Cheng Li,et al.  DNA-Chip Analyzer (dChip) , 2003 .